scholarly journals A correlation study between hyperthyroidism and some apoptosis markers among Iraqi patients

2021 ◽  
pp. 1484-1493
Author(s):  
Zainab A. Maaroof ◽  
Shaima R. Ibraheem ◽  
Aida H. Ibrahim
Keyword(s):  
Thyroid Tissue ◽  
Significant Negative Correlation ◽  
Correlation Study ◽  
Control Group ◽  
Newly Diagnosed ◽  
Hormone Production ◽  
Autoimmune Antibodies ◽  
Tnf Α ◽  
Apoptosis Markers ◽  
Α Level

This study was carried out in the Center of Endocrinology and Diabetes in Baghdad during the period between October 2019 to February 2020. The aim was to measure the level of some apoptosis markers and some autoimmune antibodies related to the thyroid gland in Iraqi patients with hyperthyroidism and evaluate the correlation between all the measured parameters. The study included 88 patients who were divided into three groups; group 1 included 30 newly diagnosed hyperthyroidism patients (24 females, 6 males); group 2 included  30 patients of hyperthyroidism who were under treatment (28, 2 males); group 3 included 28 healthy individuals as control group (22 females, 6 males).      Most of the patient's ages ranged between 40 to 60 years (73.3%), while60.7% of the control group were within the same age category. The highest rate of disease was in females compared with males (86.7% vs. 13.3%). The current study included 30% of newly diagnosed hyperthyroid patients and 30% of patients undergoing treatment for a while. The majority of the hyperthyroidism patients, both newly diagnosed and treated, were overweight, and they accounted for 53.3% of each group.    Highly significant differences (p=0.001) were found in the level of TNF-α in the newly diagnosed and under treatment patient groups in comparison with the level in the control group. The results show a significant decrease in TNF-α level in the treated patients as compared to its levels in the other groups, which indicates that this factor is affected by the given therapy.    It was found that 25% of the patients with hyperthyroidism were suffering from diabetes, with a significant correlation (p=0.009) between hyperthyroidism and diabetes mellitus. It was observed that these patients have a significant increase (p=0.038) in the level of p53 as compared to its level in patients with non-diabetic hyperthyroidism patients and healthy subjects.     This study shows a non-significant negative correlation between TNF-α and TSH levels (r= -0.06) and a non-significant positive correlation between TNF-α and p53 levels (r= 0.17) in hyperthyroidism patients.      The positive correlations between some apoptosis markers and anti-TSHR antibodies and between TSH and these antibodies in hyperthyroidism patients refers to an increase in the concentration of apoptosis markers, which may lead to an increase in the levels of thyroid autoantibodies, which affects thyroid tissue potency and increases thyroid hormone production.

scholarly journals Study the association between IL-17 level and autoimmune antibodies in hypo and hyper thyroidisms patients

2019 ◽  
pp. 1967-1976
Author(s):  
Marwah F. Fadhil ◽  
Shaima R. Ibraheem ◽  
Abdul Al-Kareem A. Al-Kazaz
Keyword(s):  
Significant Positive Correlation ◽  
Feedback Inhibition ◽  
Thyroid Tissue ◽  
Control Group ◽  
Endocrine Gland ◽  
Hormone Production ◽  
Positive Correlation ◽  
Autoimmune Antibodies ◽  
Hypothyroid Patients ◽  
Hyperthyroid Patients

     The current study included measuring the level of IL-17A and IL-17F and some autoimmune antibodies related to the thyroid gland in case of  hypo and hyperthyroid in Iraqi patients to evaluate the correlation between all the measured parameters in this study.The study has been carried out in AL-Kindey Endocrine Gland and Diabetic Center in Baghdad during the period between February 2018 and May 2018, included:  88 patients were divided into three groups, The first group composed of 30 patients of Hypothyroidism that included (26) of them were females, (4) of them males. The second group composed of 30 of patients  of Hyperthyroidism  that included (20) of them were females, (10) of them were males . and second groups were conducted with hypo and hyperthyroidism respectively.While the third group composed of  28 of healthy individuals (Control) that composed of (25) of them were females, (3) of them were males was represented as control .The results revealed a  significant (P < 0.05) correlation between TSH concentration and age in patients groups. When the age is more than 40 years, the concentration of TSH was noticed to be higher than that in patients aged less than 40 years. The results show that the level of antibodies was significantly increased (P<0.01) in hypo and hyperthyroid patients in comparison with the control group. At the same time the level of Anti-TG antibodies was higher significantly in the hypothyroid patients than its level in hyperthyroid patients group. No significant differences have been found between hypo and hyperthyroid patients in the level of Anti-TPO and Anti TSH-R antibodies. But its noticed that the higher level of Anti-TPO Ab. was found in the hypothyroid group where as higher level of Anti TSH-R Ab. was found in the hyperthyroid group and simultaneously both types were significantly higher than their levels in the control group As well as the results demonstrated a highly significant increase (P< 0.01) in the levels of IL-17 Types (A and F) in hypo and hyperthyroid patients with bias toward the comparison with the control group. The statistical study showed a significant negative correlation between the level of TSH and Anti-TG levels (r= -0.33). While a significant positive correlation between the level of Anti-TG and level of IL-17F (r= 0.39) in hypothyroid patients.  Also in hypothyroid patients, there is a significant positive correlation between the level of Anti-TPO and IL-17A (r= 0.33). In conclusion: The positive correlation between IL-17F and Anti-TG and between IL-17A and Anti- TPO in hypothyroid patients refer to increase in the concentration of IL-17 may lead to increase the thyroid autoantibodies, which affect thyroid tissue potency, decreasing thyroid hormone production, according to feedback inhibition loop.

scholarly journals High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection

Life ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 527
Author(s):  
Lucero A. Ramon-Luing ◽  
Ranferi Ocaña-Guzman ◽  
Norma A. Téllez-Navarrete ◽  
Mario Preciado-García ◽  
Dámaris P. Romero-Rodríguez ◽  
...  
Keyword(s):  
Immune Reconstitution Inflammatory Syndrome ◽  
Immune Reconstitution ◽  
Control Group ◽  
Hiv Patients ◽  
Art Initiation ◽  
Tnf Α ◽  
Ifn Γ ◽  
Α Level ◽  
Inflammatory Syndrome

Immune reconstitution inflammatory syndrome (IRIS) is an exacerbated immune response that can occur to HIV+ patients after initiating antiretroviral therapy (ART). IRIS pathogenesis is unclear, but dysfunctional and exhausted cells have been reported in IRIS patients, and the TIM-3/Gal-9 axis has been associated with chronic phases of viral infection. This study aimed to evaluate the soluble levels of TIM-3 and Gal-9 and their relationship with IRIS development. TIM-3, Gal-9, TNF-α, IFN-γ, IL-6, TNFR1, TNFR2, E-cadherin, ADAM10, and ADAM17 were measured to search for IRIS-associated biomarkers in plasma samples from 0-, 4-, 8-, 12-, and 24-weeks after ART initiation of 61 HIV+ patients (15 patients developed IRIS, and 46 did not). We found that patients who developed IRIS had higher levels of TIM-3 [median 4806, IQR: 3206–6182] at the time of the IRIS events, compared to any other follow-up time evaluated in these patients or compared with a control group of patients who did not develop IRIS. Similarly, IRIS patients had a higher TNF-α level [median 10.89, IQR: 8.36–12.34] at IRIS events than any other follow-up time evaluated. Other molecules related to the TIM-3 and TNF-α pathway (Gal-9, IL-6, IFN-γ, TNFR1, TNFR2, ADAM-10, and ADAM-17) did not change during the IRIS events. In conclusion, our data suggest that a high level of soluble TIM-3 and TNF-α could be used as an IRIS biomarker.

scholarly journals Possible Relation of Roseolovirus Infection with Fibromyalgia / Iespējamā Roseolovīrusu Infekcijas Saistība Ar Fibromialīiju

2016 ◽  
Vol 70 (4) ◽  
pp. 205-210
Author(s):  
Svetlana Čapenko ◽  
Marija Mihailova ◽  
Santa Rasa ◽  
Angelika Krūmiņa ◽  
Zane Zazerska ◽  
...  
Keyword(s):  
Human Herpesvirus ◽  
Restriction Endonuclease Analysis ◽  
Chronic Widespread Pain ◽  
Control Group ◽  
Chain Reactions ◽  
Viral Loads ◽  
Polymerase Chain Reactions ◽  
Detection Frequency ◽  
Tnf Α ◽  
Α Level

Abstract Fibromyalgia (FM) is a chronic widespread pain disorder that impacts 0.5%-7% of the general population worldwide. The aetiology and pathogenesis of the disease are still unknown. Human herpesvirus-6 and -7 belong to the family Herpesviridae, subfamily Betaherpesvirinae, and genus Roseolovirus and are immunomodulating viruses potentially pathogenic to the nervous system. Presence of anti-HHV-6 and -HHV-7 antibodies and viral genomic sequences, viral loads, HHV-6 variant-specificity, and TNF-α level were studied in 41 FM patients and 50 healthy individuals using polymerase chain reactions, restriction endonuclease analysis and ELISA. There was no difference in the presence of anti-HHV-6 and anti-HHV-7 IgG class antibodies between FM patients and control group individuals. Viral sequences were found in 80.5% of FM patients and in 62.0% of controls. Significantly higher rate of concurrent HHV-6 and HHV-7 infection and higher viral loads in peripheral blood were detected in FM patients compared to the control group individuals. Plasma viremia was detected only in FM patients. Significantly higher TNF-α levels were detected in virus positive FM patients. From all positive cases only in two FM patients HHV-6A was revealed. Significantly higher detection frequency of concurrent HHV-6 and HHV-7 infection, simultaneous HHV-6 and HHV-7 activation, higher viral loads and TNF-α expression levels in primary FM patients than in control group individuals indicate the potential involvement of Roseoloviruses in development of this disorder.

scholarly journals Study and Determination of Aryl Hydrocarbon Receptor with Some Trace Elements in Fuel Filling Station Workers

2020 ◽  
Vol 10 (4) ◽  
pp. 233-251
Author(s):  
Bassem Abd Al-Raheem Twaij ◽  
Dr. Muthana Salam Mashkour ◽  
Dr.Hussein Kadhem Al-Hakeim
Keyword(s):  
Trace Elements ◽  
Serum Concentration ◽  
Aryl Hydrocarbon Receptor ◽  
Negative Correlation ◽  
Aromatic Hydrocarbons ◽  
Significant Negative Correlation ◽  
Correlation Study ◽  
Control Group ◽  
Aryl Hydrocarbon ◽  
Filling Station

PollutiOn is the intrOduction Of contaminantsʹ intO the natural envirOnment that cause adverseʹ change. Gasoline is a toxic and highly flammable liquid consists of various types of aliphatic hydrocarbons, olefins, benzenes and aromatic hydrocarbons including toluene, xylene and a large number of volatile compounds in addition to tetraethyl lead. Gasoline consists of different types of aliphatic hydrocarbons, aryl compounds and some trace elements. Trace elements are several important roles in human bodies, some are essential for enzymes reactions where they attract and facilitate conversion of substrate molecules to specific end products. Aryl hydrocarbon receptor (AHR) is a receptor involved in the regulation of biological responses to planar aromatic hydrocarbons.       The aim of the present study is to compare the serum AHR level in the fuel station workers (FSW) with the non-workers as a control group. The other aim is to find out a possible correlation between AHR with trace elements.              Sixty male FSW and 30 controls, from ten fuel stations at Al-Najaf City-Iraq, were participated in the present study. The AHR level in serum was measured using ELISA technique. Determine the following metal ions Zn2+, Cu2+, Fe3+, Mg2+, Na+ and K+ level in filling station workers (FSW) and control group were measured spectrophotometrically by using ready for use kits. Serum Pb level was carried out using Atomic absorption spectroscopy.              The results serum concentration of AHR in FSW group revealed a significant increase (p<0.001) as compared with the control group. No significant difference was noticed in AHR as compered in exposure ≥12years with exposure <12years in FWS. Smoking has no significant correlation with other parameters. Correlation study indicated a correlation between AHR and Age. Serum concentration of Cu2+, Zn2+, K+ and Pb in FSW group revealed a significant increase (p<0.001) as compared with the control group. While Fe3+, Na+ and Mg2+ in FSW group revealed a significant decrease (p<0.001) as compared with the control group. Correlation study indicated a significant negative correlation between serum Pb and AHR while other trace elements showed no significant correlation with AHR in FSW group. There is a significant negative correlation between serum Cu2+ with age while there is significant increase correlation between Zn2+, Mg2+ and Pb with age in FWS group.                 Conclusion of study is The role of increase AHR on the health in FSW group, attention to use safety gloves and face mask is recommended for FSW and a long follow-up to the studied group is necessary to explore the    prognosis of increase AHR in FSW.  

Association study of a functional variant of TNF-α gene and serum TNF-α level with the susceptibility of congenital heart disease in a Chinese population

2019 ◽  
Vol 95 (1128) ◽  
pp. 547-551
Author(s):  
Jun Pan ◽  
Jiang Hu ◽  
Xusheng Qi ◽  
Liqin Xu
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Luciferase Reporter Assay ◽  
Luciferase Reporter ◽  
Control Group ◽  
Reporter Assay ◽  
Tnf Α ◽  
Α Level ◽  
Dual Luciferase Reporter Assay

BackgroundCongenital heart disease (CHD) is among the leading causes of infant death worldwide. Although shortage of folate has been found potentially to contribute to CHD in the embryo, the aetiology of CHD was not completely understood. Inflammation and altered immune processes are involved in all forms of cardiac malformation, including CHD. Tumour necrosis factor-α (TNF-α), was involved in the pathogenesis of multiple kinds of heart diseases. However, no studies have systematically evaluated the associations of genetic variants of TNF-α with susceptibility of CHD.MethodsA case-control study was conducted to evaluate the associations between tagSNPs of TNF-α and CHD susceptibility. Serum level of TNF-α was assessed using ELISA. The dual luciferase reporter assay was used to evaluate the functional significance of variant rs1800629 on TNF-α transcriptional activity.ResultsWe found rs1800629 was significantly correlated with increased CHD susceptibility (OR: 1.72, 95% CI 1.26 to 2.36, p=0.001). Serum levels of TNF-α were significantly higher in CHD group (9.09±1.90 pg/mL) than that in control group (6.12±1.56 pg/mL, p<0.001). The AA genotype and AG genotype of rs1800629 was associated with higher serum TNF-α level, compared with GG genotype. The dual luciferase reporter assay showed that promoter activity was significantly increased by 57% and 76% for plasmids containing the minor A allele compared with the major G allele in H9c2 and HEK 293T, respectively.ConclusionThese results indicate that higher level of serum TNF-α increases risk of CHD, while TNF-α rs1800629 A allele might contribute to higher risk for CHD due to the increase in TNF-α expression.

The change of proinflammatory cytokine tumor necrosis factor α level in the use of meloxicam in rat model of osteoarthritis

2019 ◽  
Vol 30 (6) ◽  
Author(s):  
Junaidi Khotib ◽  
Naning Windi Utami ◽  
Maria Apriliani Gani ◽  
Chrismawan Ardianto
Keyword(s):  
Tumor Necrosis Factor ◽  
Rat Model ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Control Group ◽  
Treatment Groups ◽  
Tnf Α ◽  
Α Level ◽  
Factor Α ◽  
Necrosis Factor

Abstract Background Osteoarthritis (OA) is a chronic disease in the joints. One of the proinflammatory cytokines that is thought to have a major role in the inflammatory process, the emergence of pain, and cartilage damage in OA is tumor necrosis factor α (TNF-α). Meloxicam is a nonsteroidal anti-inflammatory drug class of drugs that is relatively selective in inhibiting the activity of cyclooxygenase 2 (COX-2) formation. This study is conducted to prove the change in TNF-α level in the use of meloxicam with model in animals suffering from OA. Methods The OA rat model was induced with sodium monoiodoacetate intra-articularly. Rats were divided into 5 groups: negative control group, positive control group, and treatment groups with various doses of meloxicam. Hyperalgesia effect was evaluated using a warm plate test, and TNF-α level was determined using enzyme-linked immunosorbent assay. Results The treatment groups that received meloxicam at a dose of 1.0, 3.0, or 10.0 mg/kg body weight (BW) did not show significant differences in rat knee joint diameter (p = 0.99), but showed a significant difference in sensitivity to heat stimulation (p = 0.02) compared to the control group. Osteoarthritis rats experienced a significant reduction in TNF-α level after being given meloxicam at a dose of 10 mg/kg BW compared with the control group. This shows that the 10 mg/kg BW of meloxicam is a potential dose in reducing the TNF-α level in OA rat models. Conclusions Based on these data, it can be concluded that the inhibition of pain and the development of OA by meloxicam in animal models may be assigned to a decreased level of TNF-α.

The TNF −308G>A Polymorphism Predicts Outcome of Patients with B-Cell Chronic Lymphocytic Leukemia In Relation to the IgVH Mutation Status

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 2421-2421
Author(s):  
Ewa Lech-Maranda ◽  
Wojciech Mlynarski ◽  
Olga Grzybowska-Izydorczyk ◽  
Maciej Borowiec ◽  
Krystyna Wyka ◽  
...  
Keyword(s):  
Lymphocytic Leukemia ◽  
Prognostic Impact ◽  
Newly Diagnosed ◽  
First Line ◽  
Mutation Status ◽  
Free Survival ◽  
Cd38 Expression ◽  
Tnf Α ◽  
Α Level ◽  
First Line Treatment

Abstract Abstract 2421 Background: Tumor necrosis factor (TNF)–α is an important pro-inflammatory cytokine involved in the modulation of lymphoma development and the balance between cell-mediated and humoral immunity. Deregulated concentrations of TNF–α have been detected in patients with lymphoma and were associated with an adverse prognosis. Evidence that the single-nucleotide polymorphism (SNP) in TNF promoter, TNF −308G>A, could be the susceptibility locus for non-Hodgkin lymphoma (NHL) has been provided by case-control studies. Therefore we tested the hypothesis that TNF −308G>A influences clinical course of B-cell chronic lymphocytic leukemia (CLL). Patients and Methods: We genotyped TNF −308G>A (rs1800629) in 278 newly diagnosed patients with CLL and 192 ethnically-matched healthy individuals using the 7900 HT Real-Time (Applied Biosystems, USA). Some randomly selected DNA samples were analysed by direct sequencing using 3130xl Genetic Analyzer (Applied Biosystems, USA). Sequence data were based on the NCI SNP500 website. The IgVH mutation status in CLL patients was performed according to the protocol described by van Dongen et al. Serum samples from the 153 newly diagnosed CLL patients were collected at the time of diagnosis and tested by an enzyme-linked immunosorbent assay (ELISA) kit for human TNF (Quantikine, R&D Systems, USA). Results: The TNF −308G>A allelic frequencies and distributions were consistent with Hardy-Weinberg equilibrium, and did not differ significantly between CLL patients and the control group. There were no significant differences between TNF allelic or genotype distributions and clinical characteristics of CLL patients at diagnosis, including age, clinical stage according to Rai classification, serum LDH and β2-microglobulin levels, surface CD38 expression, ZAP-70 expression, Döhner's cytogenetic groups, and IgVH mutation status. Neither of assessed TNF polymorphic variants was associated with response to first-line treatment, progression free survival (PFS) nor treatment free survival (TFS) that was measured from time point of diagnosis to first therapy. With a median follow-up of surviving patients of 52 months (range 1–209 months), the group of patients with TNF (−308A) allele (TNF−308AA or TNF−308AG genotypes) had significantly shorter overall survival (OS) compared to those carrying TNF (−308GG) genotype (p=0.01, log–rank test). To further characterize the prognostic impact of genetic variation in TNF on CLL patients survival, we divided the patients according to the IgVH mutation status into a IgVH unmutated (homology ≥98%) and a IgVH mutated (homology <98%) group. We found that the patients carrying TNF (−308A) allele presented significantly shorter OS in the IgVH unmutated group compared to those with TNF (−308GG) genotype (p=0.02). Of note, the TNF −308G>A polymorphism did not influence survival of patients with the IgVH mutated gene. To further investigate this difference, we analyzed the impact of TNF SNP on serum TNF-α levels in CLL patients at the time of diagnosis. We found that high TNF-α levels, greater than the median (16.84 pg/mL) value, correlated with stages III and IV according to Rai classification (p=0.001, chi2 test), elevated serum levels of LDH (p=0.01) or β2-microglobulin (p=0.001), CD38 expression ≥30% (p=0.001), ZAP-70 expression >20% (p=0.01) as well as with TNF (−308AA) genotypes (p=0.04). The patients with high TNF-α levels had significantly shorter TFS (p<0.0001) compared to those with low cytokine levels. This association retained its prognostic impact on TFS both in the IgVH unmutated (p=0.004) and mutated (p<0.0001) group. No correlations between serum TNF-α levels and response to first-line treatment or PFS were found. Furthermore, in the group with high TNF-α levels, OS was significantly shorter compared to those in the cytokine low level group (p=0.04). Interestingly, when the patients were stratified according the IgVH mutation status, the high serum TNF-α level retained its prognostic impact on shorter OS only in the IgVH unmutated group compared to the patients with low TNF-α levels (p=0.04). Conclusions: Our results indicate that the TNF −308G>A polymorphism along with the serum TNF-α level may influence CLL outcome especially in the IgVH unmutated subgroup, which points out the importance of innate immunity genes for CLL variability and prognosis. Disclosures: No relevant conflicts of interest to declare.

scholarly journals The effect of selenium on the immune status in the complex treatment of children with autoimmune thyroiditis

2019 ◽  
Vol 64 (2) ◽  
pp. 87-93
Author(s):  
G. G. Gabulov ◽  
G. I. Jabrailova
Keyword(s):  
Autoimmune Thyroiditis ◽  
Immune Status ◽  
Thyroid Tissue ◽  
Average Level ◽  
Control Group ◽  
Healthy Children ◽  
T Cell Suppression ◽  
Group I ◽  
Tnf Α ◽  
Cell Suppression

The authors studied the effect of selenium on the dynamics of immune system indicators in children with autoimmune thyroiditis. They examined 31 children (average age of 11.16 ± 0.59 years). Group I included 17 children who took selenium (100 μg per day for 6 months) along with the basic treatment. Group II (n=14) took L-thyroxin. The control group included 15 healthy children of the same age. The average level of selenium in children of Group I and II was 69.23 ± 1.52 μg / l at the beginning of the study, in the control group it was 114.8 ± 3.18 μg / l. Before treatment, children in Group I and II had T-cell suppression, the average level of all cytokines (especially TNF-α and IL-6) was significantly higher than in practically healthy children. The study demonstrated that the level of the thyroid tissue antibodies decreased significantly (p=0.001) with an increase in the level of selenium in the blood serum. By the end of the study the content of IgA (p=0.012) and IgG (p=0.044) in Group I, as well as the number of lymphocytes CD3 + (p=0.008), CD4 + (p=0.015), CD16 + / 56 + (p=0.010) significantly increased. The authors observed statistically significant decrease in the levels of TNF-α (p=0.028), IL-6 (p=0.002) and IL-1β (p=0.009) in children who took selenium in addition to the main treatment. Thus, the results of the study suggest that selenium in the complex therapy of autoimmune thyroiditis significantly reduces the titer of antithyroid antibodies and positively affects a number of important indicators of immune homeostasis in children.

scholarly journals Rubiadin exerts an acute and chronic anti-inflammatory effect in rodents

2023 ◽  
Vol 83 ◽  
Author(s):  
Romina Chitsaz ◽  
Atefeh Zarezadeh ◽  
Jinous Asgarpanah ◽  
Parvaneh Najafizadeh ◽  
Zahra Mousavi
Keyword(s):  
Inflammatory Activity ◽  
Control Group ◽  
Standard Drug ◽  
Test Models ◽  
Tnf Α ◽  
Cotton Pellet ◽  
Anti Inflammatory ◽  
Α Level ◽  
Post Hoc ◽  
Acute And Chronic Inflammation

Abstract: Rubiadin is identified as a bioactive anthraquinone that exists in some quinone rich plants. The current research was carried out to evaluate the potential anti-inflammatory impact of Rubiadin in acute and chronic inflammation test models in rodents. The anti-inflammatory activity of Rubiadin was examined in cotton pellet-induced granuloma and carrageenan-induced edema as chronic and acute inflammation models in rats. TNF-α level and histopathological changes were assessed using sampled foot tissue of rat in the acute model. Also, the IL-1β level was assessed in the chronic model. One-way ANOVA (post hoc Tukey’s) analysis was used for comparing the groups. Rubiadin (0.5 mg/kg, i.p.) induced a significant reduction in TNF α level and the paw edema compared to the control group in carrageenan test. Also, it was observed that the anti-inflammatory activity of Rubiadin (0.5 mg/kg, i.p.) is comparable to mefenamic acid (30 mg/kg, i.p.) as the standard drug. Rubiadin was effective in granuloma induced by cotton pellet concerning the granuloma and transudate formation amount. Rubiadin’s anti-inflammatory effects were associated with a significant IL-1β decrease in this model. The results suggest that Rubiadin as a natural compound can possess significant peripheral anti-inflammatory impacts.

scholarly journals Prognostic Assessment of the Inflammatory Process Activity in Sarcoidosis of Respiratory Organs: Potential Use of C-reactive Protein and TNF-α

2017 ◽  
Vol 23 (2) ◽  
Author(s):  
Mykola Ostrovskyy ◽  
Kostiantyn Shvets
Keyword(s):  
Bronchoalveolar Lavage ◽  
Blood Serum ◽  
Peripheral Blood ◽  
Inflammatory Process ◽  
Bronchoalveolar Lavage Fluid ◽  
Research Work ◽  
Lavage Fluid ◽  
Control Group ◽  
Tnf Α ◽  
Α Level

This research work is devoted to the development of new additional criteria for the activity of inflammatory process in sarcoidosis of respiratory organs. The objective is to assess the effectiveness of performed treatment of sarcoidosis of respiratory organs by using low-cost highly-sensitive inflammatory markers.Materials and methods. The study involved 68 patients with lung sarcoidosis before and after the three-month treatment. In addition to general-clinical methods of examination, patients with sarcoidosis were also determined the levels of TNF-α and СRP.Results and their discussion. Patients with active lung sarcoidosis had 17.6 times (p<0.05) increased level of CRP in bronchoalveolar lavage fluid and 9.0 times (p<0.05) increased levels in peripheral blood serum; the levels of TNF-α increased by 4.98 times (p<0.05) in bronchoalveolar lavage fluid and by 3.2 times (p<0.05) in peripheral blood serum as compared to the findings in the control group of patients. The study showed that in the group of patients, where the efficacy of the prescribed therapy was noted, the level of CRP decreased by 2.76 times (p<0.05) in bronchoalveolar lavage fluid and by 2.58 times (p<0.05) in peripheral blood serum, and the concentration of TNF-α decreased by 3.87 times (p<0.05) in bronchoalveolar lavage fluid and by 2.06 times in peripheral blood serum as compared to the initial indices.Conclusions. The decrease of TNF-α level in bronchoalveolar lavage fluid on the background of three-months treatment correlated (r=0.89; p<0.05) to the changes in peripheral blood serum; at the same time the decrease of TNF-α level in peripheral blood serum correlated (r=0.82; p<0.05) to the decrease of CRP in peripheral blood serum of patients with sarcoidosis of respiratory organs. 

Sign in / Sign up

Export Citation Format

Share Document